garcinol has been researched along with Cirrhosis, Liver in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Lawrence, L; Majeed, M; Majeed, S; Mundkur, L; Nagabhushanam, K | 1 |
Cheng, AC; Ho, CT; Hung, WL; Pan, MH; Sun, PP; Tsai, CY; Tsai, ML; Yang, CC | 1 |
2 other study(ies) available for garcinol and Cirrhosis, Liver
Article | Year |
---|---|
Novel Combinatorial Regimen of Garcinol and Curcuminoids for Non-alcoholic Steatohepatitis (NASH) in Mice.
Topics: Actins; Animals; Antioxidants; Diarylheptanoids; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Fatty Liver; Female; Fibrosis; Glutathione; Hep G2 Cells; Hepatic Stellate Cells; Humans; Inflammation; Liver; Liver Cirrhosis; Malondialdehyde; Mice; Mice, Inbred C57BL; Muscle, Smooth; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Superoxide Dismutase; Terpenes; Triglycerides | 2020 |
Protective effects of garcinol on dimethylnitrosamine-induced liver fibrosis in rats.
Topics: Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Dimethylnitrosamine; Fruit; Garcinia; Liver; Liver Cirrhosis; Male; Phosphorylation; Rats; Rats, Sprague-Dawley; Smad2 Protein; Smad3 Protein; Terpenes; Transforming Growth Factor beta1 | 2014 |